Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-over multiple dose study of GRT9906 PR versus tramadol and placebo in painful polyneuropathy
2005-001404-40Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of faxeladol in polyneuropathy (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Average pain intensity vs placebo. Started Aug 2005; status: completed.
02
Drugs
faxeladol
03
Conditions
polyneuropathy
Beyond the preview
Go deeper on 2005-001404-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001404-40.